DS17 is a molecular glue that acts as a potent degrader of cyclin K, with an EC50 of 13 nM. DS17 plays an important role in cancer research[1].

DS17 is a molecular glue that acts as a potent degrader of cyclin K, with an EC50 of 13 nM. DS17 plays an important role in cancer research[1].

DS55980254 is a potent and selective phosphatidylserine synthase 1 (PTDSS1) inhibitor[1].

DSC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DSC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSC2 Human Pre-designed siRNA Set A contains three designed siRNAs for DSC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSC3 Human Pre-designed siRNA Set A contains three designed siRNAs for DSC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSCAM Human Pre-designed siRNA Set A contains three designed siRNAs for DSCAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSCAML1 Human Pre-designed siRNA Set A contains three designed siRNAs for DSCAML1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSCC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DSCC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSEL Human Pre-designed siRNA Set A contains three designed siRNAs for DSEL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSG1 Human Pre-designed siRNA Set A contains three designed siRNAs for DSG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSG2 Human Pre-designed siRNA Set A contains three designed siRNAs for DSG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSG3 Human Pre-designed siRNA Set A contains three designed siRNAs for DSG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSG4 Human Pre-designed siRNA Set A contains three designed siRNAs for DSG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSN1 Human Pre-designed siRNA Set A contains three designed siRNAs for DSN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSP Human Pre-designed siRNA Set A contains three designed siRNAs for DSP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSPE-PEG-DBCO ammonium is the ammonium salt form of DSPE-PEG-DBCO. DSPE-PEG-DBCO ammonium is utilized in copper-free click chemistry through SPAAC conjugation with an azido-functionalized peptide ligand. DSPE-PEG-DBCO ammonium is applied in drug-delivery and nanoparticle research[1].

DSPE-PEG2K-triGalNAc is a polar lipid composed of DSPE and tri-N-acetylgalactosamine that can be used to construct liposomes target to asialoglycoprotein receptor (ASGPR).

DSPP Human Pre-designed siRNA Set A contains three designed siRNAs for DSPP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DST Human Pre-designed siRNA Set A contains three designed siRNAs for DST gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSTAP chloride (CDESA) is a cationic lipid that used in the formation of lipid nanoparticles (LNPs). DORI chloride has high transfection efficiency[1].

DSTN Human Pre-designed siRNA Set A contains three designed siRNAs for DSTN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DSTYK Human Pre-designed siRNA Set A contains three designed siRNAs for DSTYK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets. DT2216 is composed of the Bcl-2 family protein inhibitor Navitoclax (HY-10087), […]

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets. DT2216 is composed of the Bcl-2 family protein inhibitor Navitoclax (HY-10087), […]

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets. DT2216 is composed of the Bcl-2 family protein inhibitor Navitoclax (HY-10087), […]

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets. DT2216 is composed of the Bcl-2 family protein inhibitor Navitoclax (HY-10087), […]

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets. DT2216 is composed of the Bcl-2 family protein inhibitor Navitoclax (HY-10087), […]

DTA (2,4-Disulfamyl-5-trifluoromethylaniline) is a cyclic AMP phosphodiesterase inhibitor that binds to erythrocyte carbonic anhydrase[1][2].

DTBT is a six-membered heterocyclic ring that is commonly used in the preparation of organic electronic devices, such as P-type organic semiconductors (OFETs) and P-type organic photodiodes (OLEDs). DTBT has good performance in electron transmission and photoelectric conversion. DTBT polymerizes to form donor-acceptor polymers, which are used to prepare solar cells[1].

DTD1 Human Pre-designed siRNA Set A contains three designed siRNAs for DTD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTD2 Human Pre-designed siRNA Set A contains three designed siRNAs for DTD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for DTHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTL Human Pre-designed siRNA Set A contains three designed siRNAs for DTL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTNA Human Pre-designed siRNA Set A contains three designed siRNAs for DTNA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTNB Human Pre-designed siRNA Set A contains three designed siRNAs for DTNB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTNBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for DTNBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTNP is a BchE -activated near infrared (NIR) probe with blood-brain permeability. DTNP can be activated by BchE and inhibit its enzyme activity. DTNP can be used in Alzheimer’s disease (AD) research[1].

DTPA-tetra (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. DTPA-tetra (t-Bu ester) can be used for conjugation of peptides and radionuclides.

DTPA-tetra (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. DTPA-tetra (t-Bu ester) can be used for conjugation of peptides and radionuclides.

DTPA-tetra (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. DTPA-tetra (t-Bu ester) can be used for conjugation of peptides and radionuclides.

DTPA-tetra (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. DTPA-tetra (t-Bu ester) can be used for conjugation of peptides and radionuclides.

DTPA-tetra (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. DTPA-tetra (t-Bu ester) can be used for conjugation of peptides and radionuclides.

DTX1 Human Pre-designed siRNA Set A contains three designed siRNAs for DTX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTX2 Human Pre-designed siRNA Set A contains three designed siRNAs for DTX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTX3 Human Pre-designed siRNA Set A contains three designed siRNAs for DTX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTX3L Human Pre-designed siRNA Set A contains three designed siRNAs for DTX3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTX4 Human Pre-designed siRNA Set A contains three designed siRNAs for DTX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DTYMK Human Pre-designed siRNA Set A contains three designed siRNAs for DTYMK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.